Asthma: Boehringer Ingelheim announces U.S. FDA filing acceptance of NDA for Spiriva ® Respimat® in asthma

Asthma: Boehringer Ingelheim announces U.S. FDA filing acceptance of NDA for Spiriva ® Respimat® in asthma
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news